Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kanokad in coagulopathy secondary to traumatic hemorrhagic shock
2016-004247-37Phase 3Completed
- Sponsor
- CHU Grenoble Alpes
- Start
- May 2017
- Modality
- Blood Coagulation Factors → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of balfaxar in coagulopathy, sponsored by CHU Grenoble Alpes. Started May 2017; status: completed.
02
Drugs
balfaxar
03
Conditions
coagulopathy
Beyond the preview
Go deeper on 2016-004247-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004247-37.